Nebenwirkungen · Tovanor Breezhaler
Tovanor Breezhaler 44 micrograms inhalation powder, hard capsules · Abschnitt 4.8 · PDF-Seite 5
HOS-219747 · Präparat HOS-216437
The safety profile is further characterised by other symptoms related to the anticholinergic effects, including signs of urinary retention, which were uncommon. Gastrointestinal effects including gastroenteritis and dyspepsia were also observed. Adverse reactions related to local tolerability included throat irritation, nasopharyngitis, rhinitis and sinusitis.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-26T02:00:00Z · SHA-256 938ba2768f4b1b1c5a1a370ce9812628761aa9bde19d1a53b0e61150ed8c3f95 · Passage ac426908c3ace015e8d357e453586c56111d73d26a75782d3612e7c7b74a997c · Zeichen 236–598 im Abschnitt